Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.

MLA

Guery, Romain, et al. “Liposomal Amphotericin B in Travelers with Cutaneous and Muco-Cutaneous Leishmaniasis: Not a Panacea.” PLoS Neglected Tropical Diseases, vol. 11, no. 11, Nov. 2017, p. e0006094. EBSCOhost, https://doi.org/10.1371/journal.pntd.0006094.

APA

Guery, R., Henry, B., Martin-Blondel, G., Rouzaud, C., Cordoliani, F., Harms, G., Gangneux, J.-P., Foulet, F., Bourrat, E., Baccard, M., Morizot, G., Consigny, P.-H., Berry, A., Blum, J., Lortholary, O., & Buffet, P. (2017). Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea. PLoS Neglected Tropical Diseases, 11(11), e0006094. https://doi.org/10.1371/journal.pntd.0006094

Chicago

Guery, Romain, Benoit Henry, Guillaume Martin-Blondel, Claire Rouzaud, Florence Cordoliani, Gundel Harms, Jean-Pierre Gangneux, et al. 2017. “Liposomal Amphotericin B in Travelers with Cutaneous and Muco-Cutaneous Leishmaniasis: Not a Panacea.” PLoS Neglected Tropical Diseases 11 (11): e0006094. doi:10.1371/journal.pntd.0006094.